# Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence

> **NCT04984317** · EARLY_PHASE1 · SUSPENDED · sponsor: **Northwell Health** · enrollment: 20 (estimated)

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **DRUG:** onabotulinumtoxin A

## Key facts

- **NCT ID:** NCT04984317
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-02-14
- **Primary completion:** 2026-12
- **Final completion:** 2027-08
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Principal Investigator changing locations.
- **Last updated:** 2026-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04984317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04984317, "Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT04984317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*